HLA-A*03 and response to immune checkpoint blockade in patients with cancer

被引：0
|
作者：
Diamantopoulos, Leonidas N. [1 ]
Appleman, Leonard J. [2 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Med Ctr,Hillman Canc Ctr, Pittsburgh, PA 15232 USA
来源：
LANCET ONCOLOGY | 2022年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E99 / E99
页数：1
相关论文
共 50 条
  • [1] HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study
    Naranbhai, Vivek
    Viard, Mathias
    Dean, Michael
    Groha, Stefan
    Braun, David A.
    Labaki, Chris
    Shukla, Sachet A.
    Yuki, Yuko
    Shah, Parantu
    Chin, Kevin
    Wind-Rotolo, Megan
    Mu, Xinineng Jasmine
    Robbins, Paul B.
    Gusev, Alexander
    Choueiri, Toni K.
    Gulley, James L.
    Carrington, Mary
    [J]. LANCET ONCOLOGY, 2022, 23 (01): : 172 - 184
  • [2] A novel HLA-A*03 allele, HLA-A*03:71
    Yu, M.
    Hall, J. E.
    Hartman, K.
    Czech, J.
    Jennings, L.
    [J]. TISSUE ANTIGENS, 2010, 76 (04): : 331 - 331
  • [3] Atypical response patterns in Chinese patients with cancer with immune checkpoint blockade
    Cui, Yu
    Guan, Yaping
    Han, Xinyue
    Xie, Hong
    Chen, Yingcui
    Nie, Weiwei
    Wang, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IS INFLUENCED BY HLA-I GENOTYPE
    不详
    [J]. CANCER DISCOVERY, 2018, 8 (02) : 139 - 139
  • [5] Identification of two novel HLA-A alleles, HLA-A*03:181 and HLA-A*03:229 in Chinese individuals
    Tao, S. -D.
    Chen, N. -Y.
    Dong, L. -N.
    He, J.
    Zhu, F. -M.
    [J]. HLA, 2016, 87 (03) : 165 - U84
  • [6] Biomarkers of response to immune checkpoint blockade in cancer treatment
    Fujii, Takeo
    Naing, Aung
    Rolfo, Christian
    Hajjar, Joud
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 130 : 108 - 120
  • [7] Impact of endogenous glucocorticoid on response to immune checkpoint blockade in patients with advanced cancer
    Cui, Yu
    Han, Xinyue
    Liu, Hongtao
    Xie, Qi
    Guan, Yaping
    Yin, Beibei
    Xiao, Junjuan
    Feng, Dongfeng
    Wang, Xuan
    Li, Junwei
    Chen, Jinghua
    Liu, Xiaolin
    Li, Xingyu
    Nie, Weiwei
    Ma, Lin
    Liu, Hairong
    Liang, Jing
    Li, Yan
    Wang, Baocheng
    Wang, Jun
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability
    Ratovomanana, T.
    Nicolle, R.
    Cohen, R.
    Diehl, A.
    Siret, A.
    Letourneur, Q.
    Buhard, O.
    Perrier, A.
    Guillerm, E.
    Coulet, F.
    Cervera, P.
    Benusiglio, P.
    Labreche, K.
    Colle, R.
    Collura, A.
    Despras, E.
    Le Rouzic, P.
    Renaud, F.
    Cros, J.
    Alentorn, A.
    Touat, M.
    Ayadi, M.
    Bourgoin, P.
    Prunier, C.
    Tournigand, C.
    de la Fouchardiere, C.
    Tougeron, D.
    Jonchere, V.
    Bennouna, J.
    de Reynies, A.
    Flejou, J. -f.
    Svrcek, M.
    Andre, T.
    Duval, A.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 (08) : 703 - 713
  • [9] A SEROLOGICAL COMPARISON OF HLA-A*26:03 AND HLA-A*26:08
    Rowlands, Jane
    Darke, Chris
    [J]. TISSUE ANTIGENS, 2015, 85 (05): : 364 - 365
  • [10] Biomarkers for Response to Immune Checkpoint Blockade
    Ganesan, Shridar
    Mehnert, Janice
    [J]. ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 2020, 4 : 331 - 351
12345